McKesson Corporation

Money Moves

As of October 2026: Acquirer (minority owner)

Option Care Health, a leading provider of home and alternate-site infusion services, is being taken private. Private equity firm Clayton Dubilier & Rice (CD&R) and drug distributor McKesson agreed on October 6 to acquire it for $32.05 per share, about $5.8 billion in total. Option Care's board approved the deal unanimously; it is set to close in the first half of 2027.

Updated Oct 8

Money Moves

As of August 2026: Acquirer in the Precision Medicine deal

The largest US drug distributor, McKesson, agreed on August 25 to buy Precision Medicine Group for $2.25 billion. Precision runs clinical trials, biomarker labs, and payer-negotiation services for biotechnology and pharmaceutical companies.

Updated Aug 26